Treatment for Hemodialysis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hemodialysis+1 More
Eligibility
18 - 85
All Sexes
What conditions do you have?
Select

Study Summary

This trial will see if patients with some kidney function will do better with two hemodialysis treatments a week, instead of the usual three.

Eligible Conditions
  • Hemodialysis
  • Chronic Kidney Failure

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 4 weeks

4 weeks
Cognition
QOL: KDQOL36
Solute Concentration
Symptom

Trial Safety

Trial Design

0 Treatment Group

50 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,148 Previous Clinical Trials
4,074,699 Total Patients Enrolled
Palo Alto Veterans Institute for ResearchLead Sponsor
50 Previous Clinical Trials
8,206 Total Patients Enrolled
Tammy Sirich, MDPrincipal Investigator - Stanford/VA Palo Alto Health Care System
Palo Alto Veterans Institute for Research

Eligibility Criteria

Age 18 - 85 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: